AIM This study aims to examine the correlation between the specific type of diabetic macular edema (DME) identified using Optical Coherence Tomography (OCT) and various factors, including patient age, gender, diabetic profile (fasting blood sugars, postprandial blood sugars, and HbA1c), duration of Type 2 Diabetes Mellitus, and central macular thickness on OCT.

OBJECTIVE The study intends to investigate the relationships between the age of patients and DME type, gender prevalence in DME, duration of Type 2 Diabetes Mellitus and DME type, diabetic profiles and DME type, central macular thickness and DME type, and severity of diabetic retinopathy and DME type.

Introduction Diabetic maculopathy is a major cause of vision impairment in diabetic retinopathy. This study explores the relationship between DME types as determined by OCT and factors such as age, gender, diabetic profile, and diabetes duration.

Materials and Methods Conducted over one year at a tertiary health care center, the study evaluated 95 patients with diabetic maculopathy through comprehensive clinical assessments including OCT classification of DME types.

Results The findings indicated a higher prevalence of DME among males, predominantly in the 61- 70 age group. A significant association was found between diabetes duration and mixed-type DME. However, no significant correlations were observed between glycemic control measures (FBS, PPBS, HbA1c) and DME types.

Conclusion The study underscores the importance of demographic and clinical factors in understanding variations in DME types, highlighting the need for tailored management strategies to reduce vision loss risk in diabetic patients.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Human Ethics committee of Sree Balaji medical college and hospital gave ethical approval for this work Ref No. 002/SBMCH/IHEC/2022/1875

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors